
J. French Hill sold CVS Health Corp (NYSE: CVS)
J. French Hill (R-AR), a U.S. Representative, has disclosed 1 trade in CVS Health Corp (CVS) since 2025, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: J. French Hill sold $15,001 - $50,000 of CVS Health Corp (NYSE: CVS) on January 31, 2025. Since that trade, CVS is up +96.40% against the S&P 500 up +22.97%, an outperformance of +73.43%.
Data updated
J. French Hill's CVS trades vs the price
CVS is up +96.40% since J. French Hill sold on January 31, 2025, versus +22.97% for the S&P 500.
Performance since this trade
All J. French Hill CVS trades
J. French Hill & CVS trading FAQ
Is it legal for J. French Hill to trade CVS Health Corp (CVS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including CVS Health Corp (CVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did J. French Hill sell CVS?
J. French Hill disclosed a sale of $15,001 - $50,000 of CVS Health Corp (CVS) on January 31, 2025, according to public STOCK Act filings.
How has CVS performed since J. French Hill's trade?
Since J. French Hill sold CVS on January 31, 2025, the stock is up +96.40%, versus +22.97% for the S&P 500 over the same period, an outperformance of +73.43%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CVS trades?
Quantellect tracks every disclosed congressional trade in CVS Health Corp (CVS) on the CVS Health Corp congressional trading page, which aggregates filings across all members of Congress.
J. French Hill's CVS tradesAll congressional filings for CVS Health CorpJ. French Hill's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

